Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2013.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Hollie Shaner-McRae DNP RN FAAN
Venous Thromboembolism: Risk Assessment and Prophylaxis
Preventing VTE in Surgical Patients. Today’s Topics The common sense science of VTE prevention Brief history of VTE prevention techniques High yield methods.
LHD Logo Venous Thromboembolism Reducing the Risk DATE.
VTE in abdominal-pelvic surgery patients
DVT PROPHYLAXIS SUNDIP PATEL 7 / 15 / BACKGROUND Deep Vein Thrombosis is a common, yet preventable peri-operative complication Highest risk in critical.
Prevention of Venous Thromboembolism Surgical Care Improvement Project
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Prophylaxis of Venous Thromboembolism
Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
VTE Prophylaxis Updates and Clarification to the Process.
CMS Core Measures Evidence-Based Performance Measurement.
QUALITY AND YOU GUIDE for New Physicians, Dentists, Podiatrists, and Extenders.
 When untreated, general postsurgical patients risk for Deep Venous Thrombosis (DVT) is 19%-25% (Buckner, et al., 2013).  Post surgical orthopedic patients.
0 Hospital Quality Incentive Demonstration (HQID) Key Facts Three year demo ( ); extended for three additional years through Oct hospitals.
Post OP Glucose Control For Cardiac Surgery The Society of Thoracic Surgeons Workforce guidelines (Lazar, 2009) recommended cardiac surgery patients, with.
Mission To provide exceptional care to every patient every day with a spirit of warmth, friendliness and personal pride. Values - I.C.A.R.E. Integrity.
Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: September 2009 Most recently updated: October 2013.
Developed by Kathy Wonderly RN, BSPA,CPHQ Performance Improvement Coordinator Developed: October 2009 Most recently updated: September 2013.
Medication History: Keeping our patients safe. How do we get all of the correct details?
Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.
Stroke Quality Measures Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: May, 2012 Most recently updated: October,
Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: June, 2012 Most recent update: October 2013 Venous Thromboembolism (VTE) Measure.
Hospital Outpatient Department Quality Measures National Hospital Quality Measures Team Members Anesthesia Surgical Services Labor & Delivery Nursing Education.
Core Measures Evidence-Based Performance Measurement Lynne Hall, RN, BSN Green Belt Six Sigma Updated: 06/16/2011.
Peri-operative management of anticoagulation Marc Carrier MD, MSc FRCPC Assistant Professor, University of Ottawa Associate Scientist, Ottawa Health Research.
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
HEART FAILURE CORE MEASURE SET A Guide for Nursing Staff Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed:September.
Developed: December 2011 Most recent update: January 2014 Kathy Wonderly Performance Improvement Coordinator Hospital Council of Western Pennsylvania Hospital.
Venous Thromboembolism (VTE) Southern New Hampshire Medical Center Lynda Pittenger, RN, CPHQ Kathy Helberg, BSN,RN, CPHQ.
IMPLEMENTING GUIDELINES AND REDUCING PATIENT RISK OF VENOUS THROMBOEMBOLISM IN A LARGE UK TEACHING HOSPITAL Sharron Millen, Head of Clinical Pharmacy and.
Risk assessment for VTE
Prevention of Venous Thromboembolism 8 th ACCP Guidelines Chest 2008.
Mission To provide exceptional care to every patient every day with a spirit of warmth, friendliness and personal pride. Values - I.C.A.R.E. Integrity.
LIFEBLOOD THE Thrombosis CHARITY LIFEBLOOD THE Thrombosis CHARITY NICE Clinical Guideline 46.
DVT Prevention and Anticoagulant Management
Introduction to Core Measures
Surgical Care FMHGettysburgShady Grove Mont.Gen.CHCWCHS 86% of 383 pts. 90% of 337 pts 86% of 254 pts 93% of 323 pts 78% of 301 pts 93% of 874 pts Percent.
Venous Thromboembolism Prophylaxis for Medical Inpatients Heather Hofmann, rev. 4/18/14 DSR2 Mini Lecture.
Cost-Consciousness Assignment Ollie Ross DSR 2. Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines.
Hospital-Acquired VTE: What We Have Learned Martha J. Radford, MD Chief Quality Officer NYU Langone Medical Center September 2009.
Preventing Surgical Infections Through Effective Perioperative Antibiotic Administration Project Team Members: Anesthesia Infectious Disease Pharmacy Surgical.
Beginning January 1, 2012 the beta blocker measure will be expanded. To pass this measure, patients on beta blocker therapy at home, must receive one.
Core Measures 2014 Revised 11/30/13.
Safer Healthcare Now! Acute Myocardial Infarction Presented by Amanda Thompson, Safer Healthcare Now Facilitator.
Surgical Care Improvement Project SCIP National Initiatives to Improve Surgical Care.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:
Quality and Patient Safety Council May 27, 2014 Presented By Susan M. Blackhurst BS, RN & Eric Jean BSN, RN, CCRN.
Peri-Operative anticoagulation /antiplatelet therapy A Shift in Paradigm BMHGT04/29/09.
Performance Measures: CMS Hospital Inpatient Quality Reporting Program (IQR)Update As of November 2012.
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy.
Dr. Lesbia Adalgisa Rodriguez PGY3-Cook County Loyola Family Medicine Residency Program Venous Thromboembolism Prophylaxis in the Inpatient Setting.
Timing of Post-discharge Venous Thromboembolic Events and Effect of Pharmacologic Prophylaxis in Hospitalized Patients Paul J. Grant MD, Todd Greene PhD,
Making Surgery Safer: Preventing Post Operative Myocardial Infarction Departments: Anesthesia, Cardiology, General Surgery, Orthopaedics, Primary Care,
The Department of Quality and Risk Management
Care of the Surgical Patient
Understanding Rate and Rhythm Control Drugs
Core Measures: The Imperative for Quality
Surgical Care Improvement Project (SCIP)
Ortho Warfarin Dosing Protocol
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients
2.13 Copyright UKCS #
Making Surgery Safer: Preventing Post Operative Myocardial Infarctions
OBMC Core Measures January 2015
Module 3 REDUCE THE LIKELIHOOD OF PATIENT HARM ASSOCIATED WITH THE USE OF ANTICOAGULANT THERAPY.
ONLY oral unit-dose warfarin, prefilled Fragmin syringes, and premixed heparin drips are used at CHSB.
Project Team: Anesthesia Infectious Disease Pharmacy Surgical Services
Preventing Venous Thromboembolism Participating Hospital Survey
Presentation transcript:

Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2013

 To identify the patients who should receive a Beta blocker during the perioperative period.  To recognize the approved venous thromboembolism (VTE) prophylaxis for surgical patients.  To recognize the importance of the VTE prophylaxis being started with 24 hours before to 24 hours after surgery  Changes for January- September 2014 will be in italics.

 This is the only cardiac measure in the current SCIP program.  Research has shown that mortality increases when patients who are on beta-blocker therapy prior to admission do not receive a beta- blocker during the perioperative period

 For this measure the perioperative period is defined as the day prior to surgery through postoperative day two with day of surgery being day zero. It is expected that the patient will receive a dose the day before or the day of surgery, a dose on P.O. days 1 and 2.  If the patient’s length of stay is less that 2 days the administration of the beta blocker the day prior to or day of surgery only are assessed.

Nursing role  While ordering a medication is a physician responsibility, nurses should remind the physician that the patient was taking a beta blocker prior to admission.  Nursing or often anesthesia will administer the medication as ordered. Be sure to document the date and time of the administration.

 As with the other indicators if the practitioner does not order a beta blocker for patients who are on one prior to admission. He/she must document the reason for not ordering this medication. This documentation must occur each day the medication is not ordered. Acceptable reasons include having a ventricular assist device or heart transplantation..

 Acebutolol  Atenolol  Atenolol/chlorthalidone  Betapace  Betapace AF  Betaxolol  Bisoprolol  Bisoprolol/fumarate  Bisoprolol/hydrochlorothiazide  Brevibloc  Bystolic  Carvedilol  Coreg  Corgard  Corzide 40/5  Corzide 80/5 c  Esmolol 

 Inderal  Inderal LA  Inderide  Inderide LA  InnoPran XL  Labetalol  Levatol  Lopressor  Lopressor HCT  Lopressor/hydrochlorothiazide  Metoprolol  Metoprolol/hydrochlorothiazide  Metoprolol Tartrate/hydrochlorothiazide  Nadolol  Nadolol/bendroflumethiazide  Nebivolol  Nebivolol HCL  Nebivolol Hydrochloride

 Penbutolol Toprol-XL  Pindolol Trandate  Propranolol Trandale HCL  Propranolol HCL Visken  Propranolol Hydrochloride Zebeta  Propranolol/hydrochlorothiazide Ziac  Sectral  Sorine  Sotalol  Sotalol HCL  Tenoretic  Tenormin  Tenormin I.V.  Timolol  Toprol Specifications Manual for National Hospital Inpatient Quality Measures Discharges (1Q14) through (3Q14) Appendix C

 The VTE measure requires that the ordered VTE prophylaxis is initiated within 24 hours prior to the anesthesia start time to 24 hours after the anesthesia end time. This is a nursing driven measure.

 There are several groups of patients who are excluded from this indicator.  These include:  Burn patients  Patients whose total surgical time is less than 60 minutes  Patients who stay less than two nights.  Patients who are on oral anticoagulation therapy prior to admission.

 There are two types of prophylaxis. Pharmacological which include: Heparin Low molecular weight heparin such as Lovonox Factor Xa inhibitor fondaparinux –Arixtra or Xarelto Warfarin (Coumadin)

 2. Mechanical prophylaxis which include : Graduated Compression Stockings (GCS) Intermittent Pneumatic Compression Devices (IPC) Venous Foot Pump (VFP)

 Years of research have identified that the type of procedure done drives the choice of VTE prophylaxis.  The following slides show the recommendations for each category of surgery.  While ordering prophylaxis is the responsibility of the practitioner, the nurses caring for post- op patients should look for some type of order or documentation as to why nothing was ordered.

Procedure Recommended prophylaxis Elective Total Knee or Total Hip Replacement Any of the following Low molecular weight heparin Factor Xa inhibitor including oral route (Xarelto) Warfarin ICP VFP Low molecular weight heparin Aspirin Hip Fracture surgeryLow molecular weight heparin Low dose unfractionated heparin Factor Xa Inhibitor Warfarin ICP Aspirin

General SurgeryLow molecular weight inhibitor Low dose unfractionated heparin Factor Xa Inhibitor IPC Urologic SurgeryLow molecular weight inhibitor Low dose unfractionated heparin Factor Xa Inhibitor IPC Pharmacological combined with IPC or GCS

Gynecologic SurgeryLow molecular weight inhibitor Low dose unfractionated heparin Factor Xa Inhibitor IPC Pharmacological combined with IPC or GCS Intracranial NeurosurgeryLow molecular weight inhibitor Low dose unfractionated heparin IPC with or without GCS Any combination of the pharmacological and mechanical listed above.

 As you see in the previous charts the first choice of prophylaxis for VTE prevention is medication with or without any mechanical device use.  When the patient has a documented contraindication such as recent GI bleed, the mechanical device prophylaxis can be used alone.

 Regardless of the treatment ordered it must be initiated in the time frame of 24 hours prior to anesthesia start time to 24 hours after the anesthesia end time.  Nursing and Pharmacy need to work together to assure the medications are available, administered and the start time documented within this window.

 The SCIP core measure set is the most complicated of all. Not only are there the most measures but there are specific time limits designated for six of these indicators.  The role of nursing is huge. Not only do you need to know the recommendations but you must be sure that each measure is addressed within the designated timeframe.  As with the other CMS core measures each indicator requires an action and concise documentation.

 Reducing the complications of surgery continues to be one of the National Patient Safety Goals and a goal of the health care reform movement.

1. Patients who are taking a beta blocker prior to arrival for surgery and receiving general anesthesia should have a dose given during the perioperative period which ends at discharge from PACU. A. True B. False

2. The SCIP VTE measures will be met as long as you get that patient out of bed on post-op day 1. A. True B. False

3. Heparin or Lovonox can be given up to ____ hour(s) before anesthesia start time and still be considered appropriate treatment according to the SCIP guidelines. A. 4 B. 16 C. 24 D. 48

4. The first choice for VTE prophylaxis is pharmacological with or without a mechanical device. A. True B. False